InvestorsHub Logo
Followers 2
Posts 35
Boards Moderated 0
Alias Born 04/02/2014

Re: Retirednlovingit post# 28307

Wednesday, 01/14/2015 5:55:19 PM

Wednesday, January 14, 2015 5:55:19 PM

Post# of 725946

MD Anderson President Ron DePinho, M.D., said. "We believe coupling MD Anderson's unique CAR T cell approach with the powerful technologies of ZIOPHARM and Intrexon will allow us to build T cells that hit cancer harder, with greater precision, under tighter control and with potentially fewer side effects for patients. This agreement ranks as one of MD Anderson's most substantial collaborations and will provide significant resources to fuel its mission of Making Cancer History(R)."



Why isn't he talking about NWBO, as Making Cancer History.
Is it because we are not paying them 100 Milliom dollars to push our technology. Seems this will really be a conflict of intrest in promoting our trials, or theirs.

At one pont in time I thought I read that NWBO would be expanding the phase 2 trial to other Cancer Centers also. I hope they do.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News